Browse
Search
Agenda - 06-01-2021; 6-a - Opioid Litigation Memorandum of Agreement
OrangeCountyNC
>
Board of County Commissioners
>
BOCC Agendas
>
2020's
>
2021
>
Agenda - 06-01-2021 Virtual Business Meeting
>
Agenda - 06-01-2021; 6-a - Opioid Litigation Memorandum of Agreement
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/27/2021 11:50:05 AM
Creation date
5/27/2021 12:00:19 PM
Metadata
Fields
Template:
BOCC
Date
6/1/2021
Meeting Type
Business
Document Type
Agenda
Agenda Item
6-a
Document Relationships
RES-2021-036-RESOLUTION Opioid Litigation Memorandum of agreement
(Message)
Path:
\Board of County Commissioners\Resolutions\2020-2029\2021
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
44
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
31 <br /> 3. Research on improved service delivery for modalities such as SBIRT that demonstrate <br /> promising but mixed results in populations vulnerable to opioid use disorders. <br /> 4. Research on novel harm reduction and prevention efforts such as the provision of fentanyl test <br /> strips. <br /> 5. Research on innovative supply-side enforcement efforts such as improved detection of mail- <br /> based delivery of synthetic opioids. <br /> 6. Expanded research on swift/certain/fair models to reduce and deter opioid misuse within <br /> criminal justice populations that build upon promising approaches used to address other substances <br /> (e.g. Hawaii HOPE and Dakota 24/7). <br /> 7. Epidemiological surveillance of OUD-related behaviors in critical populations including <br /> individuals entering the criminal justice system, including but not limited to approaches modeled <br /> on the Arrestee Drug Abuse Monitoring (ADAM) system. <br /> 8. Qualitative and quantitative research regarding public health risks and harm reduction <br /> opportunities within illicit drug markets, including surveys of market participants who sell or <br /> distribute illicit opioids. <br /> 9. Geospatial analysis of access barriers to MAT and their association with treatment engagement <br /> and treatment outcomes. <br /> Exhibits,page 13 <br />
The URL can be used to link to this page
Your browser does not support the video tag.